M77.3
Conditions
Interventions
Group 1: Radiotherapy with a total dose of 6.0Gy applied in single fractions of 1.0Gy twice a week (total duration 3 weeks)
Group 2: Radiotherapy with a total dose of 6.0Gy in single fractions of 0.5G
Sponsors
Universitätsklinikum des Saarlandes
Eligibility
Sex/Gender
All
Age
40 Years to No maximum
Inclusion criteria
Inclusion criteria: - clinical diagnosis of a painful plantar heel spur with a minumum duration of symptoms of 6 months - radiological diagnosis of a heel spur (conventional x-ray) - facultatively ultrasound, nmr, bone scan in order to diagnose plantar fasciitis - typical clinical symptoms (pain at the calcaneus) - typical functional deficits (limitation of painful walking distance - Karnofsky performance index >= 70% - Age >= 40 years - written informed consent
Exclusion criteria
Exclusion criteria: - Radiotherapy and trauma to the foot involved in anamneses - rheumatic diseases - arterial occlusion disease - intense venous insufficiency - lymphatic edema at the foot to be irradiated - pregnancy - time of breastfeeding - psychiatric illness - person in charge by law
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Global quality of life, recorded using the SF-12 (short form 12) sum score, pain, recorded using the VAS scale (visual analogue scale); pain, use of aids for gait (orthopedic shoes); limitations during work, sports or daily life, gait using the calcaneodynia sum score published by Rowe at the following time points: before radiotherapy, after radiotherapy every 6 weeks up to 48 weeks. 6,12,24,36,48 weeks after radiotherapy the patients will be examined in the clinic, 18,30,42 weeks after radiotherapy the questionnaires will be mailed to the patients. | — |
Secondary
| Measure | Time frame |
|---|---|
| Global quality of life, recorded using the SF-12 (short form 12) single scores concerning somatic and psychic aspects of quality of life; pain, recorded using the VAS scale (visual analogue scale); pain, use of aids for gait (orthopedic shoes); limitations during work, sports or daily life, gait using the calcaneodynia single scores published by Rowe at the following time points: before radiotherapy, after radiotherapy every 6 weeks up to 48 weeks. 6,12,24,36,48 weeks after radiotherapy the patients will be examined in the clinic, 18,30,42 weeks after radiotherapy the questionnaires will be mailed to the patients. | — |
Countries
Germany
Contacts
Public ContactMarcus Niewald
Klinik für Strahlentherapie und Radioonkologie, Universitätsklinikum des Saarlandes
Outcome results
None listed